Introduction: Obstructive sleep apnea syndrome (OSAS) is a clinical condition characterised by repeated periods of partial or full obstruction of airflow throughout sleep, with impairment of the quality of life and increased mortality with socioeconomic impacts. CPAP therapy is a simple and effective treatment option for OSAS patients. To overcome the clinical and prognostic limitations of AHI-as a sole index of OSAS-the Baveno classification was recently set out and introduced into clinical practice. This study aims to analyse the effect of the Baveno classification on the optimum CPAP titration pressure.

Methods: A retrospective analysis of the records of sleep studies in two centres between 2018 and 2021 was carried out. Patients diagnosed with OSAS and recruited for CPAP titration were included. Based on the Baveno classification, the patients were categorised into four groups (A, B, C, and D).

Results: Consequently, 700 patients were analysed and 427 patients were included. A significant positive correlation was detected between the CPAP optimum titration pressure and OSAS severity, neck circumference, the oxygen desaturation index (ODI), mean oxygen saturation, the AHI, the BMI, and cumulative sleep time when the SpO was <90% (T90) on the other side (: <0.0001). A non-significant correlation was seen between the Epworth Sleepiness Scale (ESS), symptom severity, end organ impact, and Baveno classification of the CPAP optimum titration pressure (: 0.8, 0.4, 0.5, and 0.7, respectively).

Conclusions: The Baveno classification is not useful in the prediction of CPAP optimum titration pressure. However, the ODI and neck circumference were significant independent predictors of a higher CPAP titration pressure.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10740694PMC
http://dx.doi.org/10.3390/arm91060042DOI Listing

Publication Analysis

Top Keywords

baveno classification
16
cpap titration
12
titration pressure
8
obstructive sleep
8
sleep apnea
8
apnea syndrome
8
cpap
5
sleep
5
patients
5
baveno
4

Similar Publications

Obstructive Sleep Apnoea (OSA) is associated with the development of cardiovascular disease (CVD); however, the risk is only weekly related to OSA severity traditionally determined by the apnoea-hypopnoea index. The Baveno classification was developed to improve patient selection who would benefit from OSA treatment in terms of symptoms improvement and CVD risk reduction. However, it is unclear how the classification relates to biomarkers of CVD risk.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates a modified "Baveno classification" for treating obstructive sleep apnoea (OSA) by incorporating a cardiovascular disease (CVD) risk score and considering severe breathing issues.
  • Researchers analyzed data from 8,625 OSA patients, categorizing them into risk groups and assessing the impact of treatment over 12-24 months using results from the Epworth Sleepiness Scale (ESS) and systolic blood pressure (SBP).
  • Findings show that treatment indications increased with higher CVD risk, and significant improvements in sleepiness and blood pressure were noted, supporting the importance of CVD assessment in OSA management.
View Article and Find Full Text PDF

A new perspective on OSAS cases with the Baveno classification.

Postgrad Med

August 2024

Department of Biostatistics and Medical Informatics, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey.

Objective/background: Since the apnea-hypopnea index (AHI), which is used in the diagnosis and grading of OSAS, does not adequately reflect the clinical perspective of the disease, the Baveno classification of OSA was developed, which allows multicomponent evaluation of OSAS patients. The aim of our study was to evaluate the application of the Baveno classification in clinical practice.

Patients/methods: A prospective study was performed on patients diagnosed with OSAS between January 2021 and June 2022.

View Article and Find Full Text PDF
Article Synopsis
  • The Baveno VII guidelines aim to help determine which patients with chronic liver disease can skip esophagogastroduodenoscopy (EGD) screening for varices.
  • A study compared the prevalence of gastric neoplasia in 481 patients with compensated advanced chronic liver disease (cACLD) to 1,364 healthy individuals who underwent EGD.
  • Results showed a significantly higher rate of gastric neoplasia in cACLD patients (4.0% versus 1.0% in healthy individuals), suggesting that EGD remains important for cACLD patients, especially in areas with a higher risk of gastric cancer.
View Article and Find Full Text PDF

 To evaluate the clinical utility of the Baveno classification in predicting incident cardiovascular mortality after five years of follow-up in a clinic-based cohort of patients with obstructive sleep apnea (OSA).  We evaluated the reproducibility of the Baveno classification using data from the Santiago Obstructive Sleep Apnea (SantOSA) study. The groups were labeled Baveno A (minor symptoms and comorbidities), B (severe symptoms and minor comorbidities), C (minor symptoms and severe comorbidities), and D (severe symptoms and comorbidities).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!